Albumin: Is It a Play-Maker, a Carrier or Both?

  • F. Mercuriali
  • G. Inghilleri
Conference paper


Albumin is a small highly symmetric, slightly heterogeneous protein weighting 67,000 D with a high cysteine content, composed by 584 aminoacids residues stabilized by 17 internal disulfide bridges. The complete aminoacid sequence maintains high homology through the species [1] and in humans, a relatively high polimorphism is present [2]. In the human genomic it has been found only one copy of the albumin gene on chromosome 4 in bands q11–22 [3].


Human Serum Albumin Oncotic Pressure Therapeutic Plasma Exchange Crystalloid Solution Academic Health Center 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Dugaiczyk A, Law SW, Dennison OE (1982) Nucleotide sequence and the encoded amino acids of human serum albumin mRNA. Proc Natl Acad Sci USA 79:71–75PubMedCrossRefGoogle Scholar
  2. 2.
    Carlson P, Sakamoto Y, Laurell C et al (1992) Alloalbuminemia in Sweden: Structural study and phenotypic distribution of nine albumin variants. Proc Natl Acad Sci USA 89:8225–8229PubMedCrossRefGoogle Scholar
  3. 3.
    Peters Jr (1985) The serum albumin. Adv Prot Chem 37:161–245CrossRefGoogle Scholar
  4. 4.
    Urban J, Inglis AS, Edwards K et al (1974) Chemical evidence for the difference between albumins from microsomes and serum and a possible precursor product relationship. Biochem Biophys Res Commun 61(2):494–501PubMedCrossRefGoogle Scholar
  5. 5.
    Sgouris JT, Rene A (eds) Proceedings of the Workshop on Albumin, 1975. Bethesda, Mid, National Heart and Lung Institute 1976, US Dept of Health, Education, and Welfare publication NIH 76–925Google Scholar
  6. 6.
    Tullis JL (1977) Albumin. Background and use. JAMA 237:355–360PubMedCrossRefGoogle Scholar
  7. 7.
    Simonescu N (1979) The microvascular endothelium: Segmental differentiations; transcytosis, selective distribution of anionic sites. In: Weissmann G, Samuelson B, Paoletti R (eds) Advance in Inflammation Research. Vol 1. Raven Press, NY, p 61Google Scholar
  8. 8.
    Watkins S, Madison J, Galliano M et al (1994) Analbuminemia: Three cases resulting from different point mutations in the albumin gene. Proc Natl Acad Sci USA 91:9417–9421PubMedCrossRefGoogle Scholar
  9. 9.
    Falkenberg C, Bjork L, Akerstrom B (1992) Localization of the binding site for streptococcal proteins G on human serum albumin. Identification of a 5.5-kilodalton protein G binding albumin fragment. Biochemistry 31:14551–14557CrossRefGoogle Scholar
  10. 10.
    Grootendorst AF, van Wilgenburg MG, de Laat PH et al (1988) Albumin abuse in intensive care medicine. Intens Care Med 14:554–557CrossRefGoogle Scholar
  11. 11.
    Grunett A (1991) Osmometrie und Onkometrie in der intensivmedizinischen Diagnostik und Therapie. Schweiz. Z Milit Med 68:69–73Google Scholar
  12. 12.
    James WPT, Hay AM (1988) Albumin metabolism: effect of albumin supplementation during parenteral nutrition on hospital morbidity. Crit Care Med 16:1177–1182CrossRefGoogle Scholar
  13. 13.
    Rothschild MA, Oratz M, Mongelli J (1968) Effects of a short-term fast on albumin synthesis: Studies in vivo, in the perfused liver, and on amino acid incorporation by hepatic microsomes. J Clin Invest 47:2591PubMedCrossRefGoogle Scholar
  14. 14.
    Mosnage HJ, Janssen JAM, Franssen JH et al (1987) Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation. J Clin Invest 79:1635–1641CrossRefGoogle Scholar
  15. 15.
    Saunders LW, Schmidt BJ, Mallona RL et al (1987) Secretion of human serum albumin from Bacillus subtilis. J Bacteriol 169:2917PubMedGoogle Scholar
  16. 16.
    Cohn EJ, Strong LE, Hughes WL Jr et al (1946) Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the proteins and lipoprotein components of biological tissues and fluids. J Am Chem Soc 68:459PubMedCrossRefGoogle Scholar
  17. 17.
    Erstad BL, Gales B, Rappaport WD (1991) The use of albumin in clinical practice. Arch Intern Med 151:901–911PubMedCrossRefGoogle Scholar
  18. 18.
    Swisher SN (ed) Report of Panel 6 on safety and efficacy of blood and blood derivatives. Bureau of Biologies, Food and Drug Administration. The Federal Register 1980Google Scholar
  19. 19.
    Bowman JM (1995) Hemolytic disease of the fetus and newborn. 1995 Conn’s Current Ther (Rakel RE, Ed) Saunders, Philadelphia 329–334Google Scholar
  20. 20.
    Grant JP (1994) Nutritional support in critically ill patients. Ann Surg 220:610–616PubMedCrossRefGoogle Scholar
  21. 21.
    Gines P, Arroyo V, Vargas V et al (1991) Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosic with refractory ascites. New Engl J Med 325:829–835PubMedCrossRefGoogle Scholar
  22. 22.
    Finkelstein JL, Schwartz SB, Madden MR, et al (1992) Pediatric burns: An overview. In: Di Maio (ed) Pediatric emergency medicine. Ped Clin North America 39:1145–1164Google Scholar
  23. 23.
    James WPT, Hay AM (1968) Albumin metabolism: Effect of the nutritional state and the dietary protein intake. J Clin Invest 47:1958–1972PubMedCrossRefGoogle Scholar
  24. 24.
    Waterhouse C, Bassett SH, Holler J (1949) Metabolic studies on protein depleted patients receiving a large part of their nitrogen intake from human serum albumin administered intravenously. J Clin Invest 28:245CrossRefGoogle Scholar
  25. 25.
    Pattison CP, Klein CA, Leger RT et al (1976) Field studies of type B hepatitis associated with transfusion of plasma protein fraction. In: Sgouris JT, Rene A (eds) Proceedings of the Workshop on Albumin, p 315Google Scholar
  26. 26.
    Wells MA, Wittek AE, Epstein JS et al (1986) Inactivation and partition of T-cell lymphotrophic virus, type III, during ethanol fractionation of plasma. Transfusion 26:210–215PubMedCrossRefGoogle Scholar
  27. 27.
    Alving BM, Hojima Y, Pisano JJ et al (1978) Hypotension associated with prekallikrein activator (Hageman-factor fragments) in plasma protein fraction. N Engl J Med 299:66PubMedCrossRefGoogle Scholar
  28. 28.
    Maharaj D, Fell GS, Boyce BF et al (1987) Aluminium bone disease in patients receiving plasma exchange with contaminated albumin. Brit Med J 295:693–696CrossRefGoogle Scholar
  29. 29.
    Recknagel S, Bratter P, Crissafidou A et al (1994) Parenteral aluminum loading in critical care medicine part I: Aluminum content of infusion solutions and solutions for parenteral nutrition. Infusionssther Transfusionsmed 21:266–273Google Scholar
  30. 30.
    Development Task Force of the College of American Pathologists (1994) Practice parameters for the use of fresh-frozen plasma, cryoprecipitate, and platelet administration practice guidelines. JAMA 271:777CrossRefGoogle Scholar
  31. 31.
    Devine P, Linden JV, Hoffstadter LK et al (1993) Blood donor-, apheresis-, and transfusion-related activities: results of the 1991 American Association of Blood Banks Institutional Membership Questionnaire. Transfusion 33:779PubMedCrossRefGoogle Scholar
  32. 32.
    Vermeulen LC, Ratko TA, Erstad BL et al (1995) A paradigm for Consensus. The University hospital consortium guidelines for the use of albumin, nonprotein colloid and crystalloid solutions. Arch Intern Med 155:373–379PubMedCrossRefGoogle Scholar
  33. 33.
    Yim JM, Vermeulen LV, Erstad BI et al (1995) Albumin and non protein colloid solution use in US academic health centers. Arch Intern Med 155:2450–2455PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1999

Authors and Affiliations

  • F. Mercuriali
    • 1
  • G. Inghilleri
    • 1
  1. 1.Immunohaematologic and Transfusional CentreG. Pini Orthopaedic InstituteMilanItaly

Personalised recommendations